keyword
https://read.qxmd.com/read/38497717/th1-cell-immune-response-in-talaromyces-marneffei-infection-with-anti-interferon-%C3%AE-autoantibody-syndrome
#21
JOURNAL ARTICLE
Ye Qiu, Zheng-Tu Li, Wen Zeng, Jing-Lu Yang, Meng-Xin Tang, Yan Wang, Hao-Ru Wang, Yuanxiang Li, Yang-Qing Zhan, Shao-Qiang Li, Jian-Quan Zhang, Feng Ye
Anti-interferon-γ autoantibody (AIGA) syndrome may be the basis of disseminated Talaromyces marneffei infection in human immunodeficiency virus (HIV)-negative adults. However, the pathogenesis of Th1 cell immunity in T. marneffei infection with AIGA syndrome is unknown. A multicenter study of HIV-negative individuals with T. marneffei infection was conducted between September 2018 and September 2020 in Guangdong and Guangxi, China. Patients were divided into AIGA-positive (AP) and AIGA-negative (AN) groups according to the AIGA titer and neutralizing activity...
March 18, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38490721/serum-cytokine-biosignatures-for-identification-of-tuberculosis-among-hiv-positive-inpatients
#22
JOURNAL ARTICLE
Huihua Zhang, LingHua Li, YanXia Liu, Wei Xiao, RuiYao Xu, MengRu Lu, WenBiao Hao, YuChi Gao, Xiaoping Tang, Youchao Dai
BACKGROUND: Serum cytokines correlate with tuberculosis (TB) progression and are predictors of TB recurrence in people living with HIV. We investigated whether serum cytokine biosignatures could diagnose TB among HIV-positive inpatients. METHODS: We recruited HIV-positive inpatients with symptoms of TB and measured serum levels of inflammation biomarkers including IL-2, IL-4, IL-6, IL-10, tumour necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ)...
March 15, 2024: Thorax
https://read.qxmd.com/read/38466776/computationally-inferred-cell-type-specific-epigenome-wide-dna-methylation-analysis-unveils-distinct-methylation-patterns-among-immune-cells-for-hiv-infection-in-three-cohorts
#23
JOURNAL ARTICLE
Xinyu Zhang, Ying Hu, Ral E Vandenhoudt, Chunhua Yan, Vincent C Marconi, Mardge H Cohen, Zuoheng Wang, Amy C Justice, Bradley E Aouizerat, Ke Xu
BACKGROUND: Epigenome-wide association studies (EWAS) have identified CpG sites associated with HIV infection in blood cells in bulk, which offer limited knowledge of cell-type specific methylation patterns associated with HIV infection. In this study, we aim to identify differentially methylated CpG sites for HIV infection in immune cell types: CD4+ T-cells, CD8+ T-cells, B cells, Natural Killer (NK) cells, and monocytes. METHODS: Applying a computational deconvolution method, we performed a cell-type based EWAS for HIV infection in three independent cohorts (Ntotal = 1,382)...
March 11, 2024: PLoS Pathogens
https://read.qxmd.com/read/38461021/late-onset-diffuse-lung-disease-in-an-8-year-old-girl
#24
Huiying Wang, Yu Tang, Yuelin Shen
An 8-year-old girl presented with a 34-day history of cough, fatigue, and impaired exercise tolerance. She experienced cyanosis on exertion but denied fever, hemoptysis, hematuria, or seizures. Her perinatal and family histories were unremarkable, and she had no history of exposure to TB. A chest radiogram from a local clinic showed diffuse pulmonary lesions. Tuberculin skin test, interferon-γ release assay, and HIV antibody test results were all negative. Immunoglobulin levels and lymphocyte subsets were normal...
March 2024: Chest
https://read.qxmd.com/read/38421058/nucleotide-metabolism-leukodystrophies-and-cns-pathology
#25
JOURNAL ARTICLE
Francesco Gavazzi, Carlos Dominguez Gonzalez, Kaley Arnold, Meghan Swantkowski, Lauren Charlton, Nicholson Modesti, Asif A Dar, Adeline Vanderver, Mariko Bennett, Laura A Adang
The balance between a protective and a destructive immune response can be precarious, as exemplified by inborn errors in nucleotide metabolism. This class of inherited disorders, which mimics infection, can result in systemic injury and severe neurologic outcomes. The most common of these disorders is Aicardi Goutières syndrome (AGS). AGS results in a phenotype similar to "TORCH" infections (Toxoplasma gondii, Other [Zika virus (ZIKV), human immunodeficiency virus (HIV)], Rubella virus, human Cytomegalovirus [HCMV], and Herpesviruses), but with sustained inflammation and ongoing potential for complications...
February 29, 2024: Journal of Inherited Metabolic Disease
https://read.qxmd.com/read/38411599/systemic-inflammation-in-pregnant-women-with-hiv-relationship-with-hiv-treatment-regimen-and-preterm-delivery
#26
JOURNAL ARTICLE
Rupak Shivakoti, Mark J Giganti, Michael M Lederman, Rachel Ketchum, Sean Brummel, Daniela Moisi, Sufia Dadabhai, Dhayendre Moodley, Avy Violari, Lameck Chinula, Maxensia Owor, Amita Gupta, Judith S Currier, Taha E Taha, Mary Glenn Fowler
OBJECTIVE: : HIV treatment regimen during pregnancy was associated with preterm delivery (PTD) in the PROMISE 1077 BF trial. Systemic inflammation among pregnant women with HIV could help explain differences in PTD by treatment regimen. We assessed associations between inflammation, treatment regimen, and PTD. DESIGN/METHODS: : A nested 1:1 case-control study (N = 362) was conducted within a multi-country randomized trial comparing three HIV regimens in pregnant women: zidovudine alone, or combination antiretroviral therapy (ART) with lopinavir/ritonavir and either zidovudine or tenofovir...
February 26, 2024: AIDS
https://read.qxmd.com/read/38400115/t-cell-responses-against-orthopoxviruses-in-hiv-positive-patients
#27
JOURNAL ARTICLE
Sammet Stefanie, Michael Koldehoff, Pia Schenk-Westkamp, Peter A Horn, Stefan Esser, Monika Lindemann
A global outbreak of predominantly sexually transmitted mpox infections, outside endemic regions, was reported in May 2022. Thereafter, risk groups were vaccinated against smallpox, a structurally related orthopoxvirus. In the current study, we analyzed T cell responses against peptides derived from orthopoxviruses in 33 HIV-positive patients after two vaccinations against smallpox and in 10 patients after mpox infection. We established an ELISpot assay, detecting either the secretion of the pro-inflammatory cytokine interferon (IFN)-γ or interleukin (IL)-2...
January 27, 2024: Vaccines
https://read.qxmd.com/read/38399945/selected-milestones-in-antiviral-drug-development
#28
REVIEW
Erik De Clercq
This review article will describe the (wide) variety of approaches that I envisaged to develop a specific therapy for viral infections: (i) interferon and its inducers, (ii) HSV, VZV and CMV inhibitors, (iii) NRTIs (nucleoside reverse transcriptase inhibitors), NtRTIs (nucleotide reverse transcriptase inhibitors) and NNRTIs (non-nucleoside reverse transcriptase inhibitors) as HIV inhibitors, (iv) NtRTIs as HBV inhibitors, and finally, (v) the transition of an HIV inhibitor to a stem cell mobilizer, as exemplified by AMD-3100 (Mozobil® )...
January 23, 2024: Viruses
https://read.qxmd.com/read/38385642/tailoring-t-fh-profiles-enhances-antibody-persistence-to-a-clade-c-hiv-1-vaccine-in-rhesus-macaques
#29
JOURNAL ARTICLE
Anil Verma, Chase E Hawes, Sonny R Elizaldi, Justin C Smith, Dhivyaa Rajasundaram, Gabriel Kristian Pedersen, Xiaoying Shen, LaTonya D Williams, Georgia D Tomaras, Pamela A Kozlowski, Rama R Amara, Smita S Iyer
CD4 T follicular helper cells (Tfh ) are essential for establishing serological memory and have distinct helper attributes that impact both the quantity and quality of the antibody response. Insights into Tfh subsets that promote antibody persistence and functional capacity can critically inform vaccine design. Based on the Tfh profiles evoked by the live attenuated measles virus vaccine, renowned for its ability to establish durable humoral immunity, we investigated the potential of a Tfh 1/17 recall response during the boost phase to enhance persistence of HIV-1 Envelope (Env) antibodies in rhesus macaques...
February 22, 2024: ELife
https://read.qxmd.com/read/38385222/magnitude-of-type-i-interferon-responses-by-plasmacytoid-dendritic-cells-after-tlr7-stimulation-is-associated-with-human-immunodeficiency-virus-type-1-hiv-1-reservoir-sizes-in-cisgender-women-with-hiv-1-on-antiretroviral-therapy
#30
JOURNAL ARTICLE
Rebecca-Jo Thiele, Benjamin Grünhagel, Maximilian Muenchhoff, Maria Pujantell-Graell, Linda Jocham, Arne Düsedau, Jana Hennesen, Heike Hildebrandt, Sven Hendrik Hagen, Deborah Sandfort, Madeleine J Bunders, Oliver T Keppler, Christian Hoffmann, Marcus Altfeld
Human immunodeficiency virus type 1 (HIV-1) disease manifestations differ between cisgender women and men, including better control of viral replication during primary infection and less frequent residual HIV-1 replication on antiretroviral therapy (ART) in cisgender women with HIV-1 (WWH). Investigating plasmacytoid dendritic cell (pDC) functions and HIV-1 reservoir sizes in 20 WWH on stable ART, we observed inverse correlations between interferon-α and tumor necrosis factor responses of pDCs to Toll-like receptor 7/8 stimulation and intact/total proviral HIV-1 DNA levels...
February 22, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38372203/myxovirus-resistance-protein-a-mxa-expression-in-myositides-sarcoplasmic-expression-is-common-in-both-dermatomyositis-and-lupus-myositis
#31
JOURNAL ARTICLE
Changhong Xing, Jaya Trivedi, Nicole Bitencourt, Dennis K Burns, Joan S Reisch, Chunyu Cai
INTRODUCTION/AIMS: Myxovirus resistance protein A (MxA) is a type I interferon (IFN1) pathway activation marker and MxA sarcoplasmic expression is currently recognized as a highly specific marker for dermatomyositis (DM). However, we have frequently observed endothelial tubuloreticular inclusions (TRI), another surrogate IFN1 activation marker, in a variety of overlap myositides. The aim of this study was to examine MxA expression in those myositides. METHODS: We retrospectively performed MxA immunostaining on a wide range of myositides...
February 19, 2024: Muscle & Nerve
https://read.qxmd.com/read/38368384/covid-19-immune-signatures-in-uganda-persist-in-hiv-co-infection-and-diverge-by-pandemic-phase
#32
JOURNAL ARTICLE
Matthew J Cummings, Barnabas Bakamutumaho, Julius J Lutwama, Nicholas Owor, Xiaoyu Che, Maider Astorkia, Thomas S Postler, John Kayiwa, Jocelyn Kiconco, Moses Muwanga, Christopher Nsereko, Emmanuel Rwamutwe, Irene Nayiga, Stephen Kyebambe, Mercy Haumba, Henry Kyobe Bosa, Felix Ocom, Benjamin Watyaba, Bernard Kikaire, Alin S Tomoiaga, Stevens Kisaka, Noah Kiwanuka, W Ian Lipkin, Max R O'Donnell
Little is known about the pathobiology of SARS-CoV-2 infection in sub-Saharan Africa, where severe COVID-19 fatality rates are among the highest in the world and the immunological landscape is unique. In a prospective cohort study of 306 adults encompassing the entire clinical spectrum of SARS-CoV-2 infection in Uganda, we profile the peripheral blood proteome and transcriptome to characterize the immunopathology of COVID-19 across multiple phases of the pandemic. Beyond the prognostic importance of myeloid cell-driven immune activation and lymphopenia, we show that multifaceted impairment of host protein synthesis and redox imbalance define core biological signatures of severe COVID-19, with central roles for IL-7, IL-15, and lymphotoxin-α in COVID-19 respiratory failure...
February 17, 2024: Nature Communications
https://read.qxmd.com/read/38367616/selection-of-epigenetically-privileged-hiv-1-proviruses-during-treatment-with-panobinostat-and-interferon-%C3%AE-2a
#33
JOURNAL ARTICLE
Marie Armani-Tourret, Ce Gao, Ciputra Adijaya Hartana, WeiWei Sun, Leah Carrere, Liliana Vela, Alexander Hochroth, Maxime Bellefroid, Amy Sbrolla, Katrina Shea, Theresa Flynn, Isabelle Roseto, Yelizaveta Rassadkina, Carole Lee, Francoise Giguel, Rajeev Malhotra, Frederic D Bushman, Rajesh T Gandhi, Xu G Yu, Daniel R Kuritzkes, Mathias Lichterfeld
CD4+ T cells with latent HIV-1 infection persist despite treatment with antiretroviral agents and represent the main barrier to a cure of HIV-1 infection. Pharmacological disruption of viral latency may expose HIV-1-infected cells to host immune activity, but the clinical efficacy of latency-reversing agents for reducing HIV-1 persistence remains to be proven. Here, we show in a randomized-controlled human clinical trial that the histone deacetylase inhibitor panobinostat, when administered in combination with pegylated interferon-α2a, induces a structural transformation of the HIV-1 reservoir cell pool, characterized by a disproportionate overrepresentation of HIV-1 proviruses integrated in ZNF genes and in chromatin regions with reduced H3K27ac marks, the molecular target sites for panobinostat...
February 16, 2024: Cell
https://read.qxmd.com/read/38360376/interferon-%C3%AE-deficiency-alters-brain-response-to-chronic-hiv-1-envelope-protein-exposure-in-a-transgenic-model-of-neurohiv
#34
JOURNAL ARTICLE
Hina Singh, Jeffrey Koury, Ricky Maung, Amanda J Roberts, Marcus Kaul
Human immunodeficiency virus-1 (HIV-1) infects the central nervous system (CNS) and causes HIV-associated neurocognitive disorders (HAND) in about half of the population living with the virus despite combination anti-retroviral therapy (cART). HIV-1 activates the innate immune system, including the production of type 1 interferons (IFNs) α and β. Transgenic mice expressing HIV-1 envelope glycoprotein gp120 (HIVgp120tg) in the CNS develop memory impairment and share key neuropathological features and differential CNS gene expression with HIV patients, including the induction of IFN-stimulated genes (ISG)...
February 13, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38325411/real-world-effectiveness-and-safety-of-glecaprevir-pibrentasvir-for-the-treatment-of-chronic-hepatitis-c-a-prospective-cohort-study-in-portugal
#35
JOURNAL ARTICLE
José Vera, André Gomes, Diana Póvoas, Diana Seixas, Fernando Maltez, Isabel Pedroto, Luís Maia, Margarida Mota, Maria João Vieira, Maria José Manata, Paula Ferreira, Sara Lino, Tiago Pereira Guedes, Vânia Barradas, Nuno Marques
INTRODUCTION: Information about pan-genotypic treatments for hepatitis in Portugal is scarce. We aimed to evaluate the effectiveness and safety of glecaprevir plus pibrentasvir (GLE/PIB) treatment for hepatitis C virus (HCV) infection in real-world clinical practice. METHODS: An observational prospective study was implemented in six hospitals with 121 adult HCV patients who initiated treatment with GLE/PIB between October 2018 and April 2019, according to clinical practice...
February 7, 2024: Acta Médica Portuguesa
https://read.qxmd.com/read/38318650/antiviral-factors-and-their-counteraction-by-hiv-1-many-uncovered-and-more-to-be-discovered
#36
JOURNAL ARTICLE
Dorota Kmiec, Frank Kirchhoff
Extensive studies on HIV-1 have led to the discovery of a variety of structurally and functionally diverse innate defense factors that target various steps of the retroviral replication cycle. Some of them, such as APOBEC3, tetherin, and SERINC5, are well established. Their importance is evident from the fact that HIV-1 uses its accessory proteins Vif, Vpu, and Nef to counteract them. However, the list of antiviral factors is constantly increasing, and the innate defense mechanisms for them to restrict HIV-1 and/or how they are counteracted by viral proteins remain to be discovered...
February 5, 2024: Journal of Molecular Cell Biology
https://read.qxmd.com/read/38318349/antiviral-response-and-hiv-1-inhibition-in-sickle-cell-disease
#37
JOURNAL ARTICLE
Namita Kumari, Asrar Ahmad, Clemilson Berto-Junior, Andrey Ivanov, Fayuan Wen, Xionghao Lin, Sharmin Diaz, Iheanyi Okpala, James G Taylor, Marina Jerebtsova, Sergei Nekhai
Sickle cell disease (SCD) is characterized by hemolysis, vaso-occlusion, and ischemia. HIV-1 infection was previously shown to be suppressed in SCD PBMCs. Here, we report that HIV-1 suppression is attributed to the increased expression of iron, hypoxia, and interferon-induced innate antiviral factors. Inhibition of upregulated antiviral genes, HMOX-1 , CDKN1A , and CH25H , increased HIV-1 replication in SCD PBMCs, suggesting their critical role in HIV-1 suppression. Levels of IFN-β were elevated in SCD patients...
February 16, 2024: IScience
https://read.qxmd.com/read/38317183/pro-inflammatory-feedback-loops-define-immune-responses-to-pathogenic-lentivirus-infection
#38
JOURNAL ARTICLE
Aaron J Wilk, Joshua O Marceau, Samuel W Kazer, Ira Fleming, Vincent N Miao, Jennyfer Galvez-Reyes, Jason T Kimata, Alex K Shalek, Susan Holmes, Julie Overbaugh, Catherine A Blish
BACKGROUND: The Lentivirus human immunodeficiency virus (HIV) causes chronic inflammation and AIDS in humans, with variable rates of disease progression between individuals driven by both host and viral factors. Similarly, simian lentiviruses vary in their pathogenicity based on characteristics of both the host species and the virus strain, yet the immune underpinnings that drive differential Lentivirus pathogenicity remain incompletely understood. METHODS: We profile immune responses in a unique model of differential lentiviral pathogenicity where pig-tailed macaques are infected with highly genetically similar variants of SIV that differ in virulence...
February 5, 2024: Genome Medicine
https://read.qxmd.com/read/38301135/interleukin-36gamma-mediates-the-in-vitro-activation-of-cd8-t-cells-from-patients-living-with-chronic-human-immunodeficiency-virus-1-infection
#39
JOURNAL ARTICLE
Yingquan Zhou, Jijun Chen, Shaoli Bai, Fan Yang, Ruqing Yan, Yanjun Song, Binfa Yang, Chao Li, Jianyun Wang
Interleukin-36 (IL-36) signaling plays an important role in promoting CD8+ T cell-mediated antitumor immune responses. The role of IL-36 signaling in CD8+ T cells that are involved in host immune responses during human immunodeficiency virus-1 (HIV-1) infection has not been characterized. Sixty-one patients living with chronic HIV-1 infection and 23 controls were enrolled in this study. The levels of IL-36 cytokine family members were measured by enzyme-linked immunosorbent assay. Purified CD8+ T cells were stimulated with recombinant IL-36gamma (1 or 10 ng/mL)...
February 1, 2024: Viral Immunology
https://read.qxmd.com/read/38290139/estimated-rates-of-progression-to-tuberculosis-disease-for-persons-infected-with-mycobacterium-tuberculosis-in-the-united-states
#40
JOURNAL ARTICLE
Mina Ekramnia, Yunfei Li, Maryam B Haddad, Suzanne M Marks, J Steve Kammerer, Nicole A Swartwood, Ted Cohen, Jeffrey W Miller, C Robert Horsburgh, Joshua A Salomon, Nicolas A Menzies
BACKGROUND: In the United States, over 80% of tuberculosis (TB) disease cases are estimated to result from reactivation of latent TB infection (LTBI) acquired more than 2 years previously ("reactivation TB"). We estimated reactivation TB rates for the US population with LTBI, overall, by age, sex, race-ethnicity, and US-born status, and for selected comorbidities (diabetes, end-stage renal disease, and HIV). METHODS: We collated nationally representative data for 2011-2012...
March 1, 2024: Epidemiology
keyword
keyword
61879
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.